Business Context and Reporting Period
Company: Interlink Electronics, Inc. (LINK)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2025
Business Overview: Interlink is a provider of sensors and printed electronics for Human-Machine Interface (HMI) and Internet-of-Things (IoT) solutions. Key markets include medical, industrial, automotive, and wearables. The company operates manufacturing facilities in the U.S., China, and the U.K.
Key Financial Metrics
| Metric | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Revenue | $3.41M | $2.90M | $6.08M | $6.02M |
| Gross Profit | $1.54M | $1.31M | $2.49M | $2.56M |
| Gross Margin | 45.0% | 45.0% | 40.9% | 42.5% |
| Net Income (Loss) | $0.10M | $(0.31M) | $(0.71M) | $(1.05M) |
| Net Income Applicable to Common | $0 | $(0.41M) | $(0.91M) | $(1.25M) |
| Cash and Equivalents (End of Period) | $2.33M | $3.96M | $2.33M | $3.96M |
| Working Capital | $5.00M | N/A | $5.00M | N/A |
| Debt | $0 (No indebtedness) | $0 | $0 | $0 |
Note: All figures in thousands except per share data and percentages. Preferred stock dividends of $0.10M (Q2) and $0.20M (YTD) were paid, reducing net income applicable to common stockholders.
Material Changes vs. Prior Period
- Revenue Growth (Q2): Revenue increased 17.8% year-over-year to $3.41M, driven by significant growth in Industrial (+87.0%) and Automotive (+130.8%) markets. This offset a 22.2% decline in the Medical market.
- Profitability Turnaround (Q2): The company reported a net income of $0.10M in Q2 2025, compared to a net loss of $0.31M in Q2 2024. Operating income improved from a loss of $0.31M to a profit of $0.07M.
- Expense Reduction: Engineering, R&D expenses decreased 28.8% in Q2 2025 compared to the prior year, primarily due to lower employee and consultant compensation costs.
- Cash Flow: Net cash used in operating activities increased to $0.41M for the six months ended June 30, 2025, compared to $0.08M in the prior year period, largely due to an increase in accounts receivable.
Outlook, Risks, and Contingencies
- Liquidity: Management believes existing cash ($2.33M) is sufficient for current operations. However, $1.5M of cash is held by foreign subsidiaries and may incur tax effects if repatriated.
- Preferred Stock Obligations: The company has 200,000 shares of 8.0% Series A Convertible Preferred Stock outstanding with a $5.0M liquidation preference. Monthly cumulative cash dividends are paid, totaling $0.20M for the six-month period.
- Customer Concentration: Two customers accounted for 17% and 13% of revenue in Q2 2025. Three customers accounted for 53% of total accounts receivable at period end.
- Risks: Key risks include supply chain disruptions, foreign currency fluctuations, reliance on key customers, and the need for potential future capital raises which could dilute common shareholders.
- Acquisition Impact: The December 2024 acquisition of Conductive Transfers is included in results; pro forma data suggests revenue would have been higher in the prior year period had the acquisition been completed earlier.
Investor Verification Checklist
- Preferred Stock Dividends: Verify the sustainability of monthly preferred dividends ($0.20M semi-annually) given the net loss applicable to common stockholders for the YTD period.
- Medical Market Decline: Investigate the specific reasons for the 22.2% drop in medical revenue and the impact of the "larger medical customer" demand reduction on future quarters.
- Cash Repatriation: Assess the tax implications and feasibility of moving the $1.5M held in foreign subsidiaries to the U.S. if needed for operations or acquisitions.
- Accounts Receivable: Review the aging of receivables, noting that three customers represent over 50% of the balance, and the increase in days-sales outstanding from 49 to 56 days.
- Related Party Transactions: Review the ongoing facility sharing and consulting agreements with Qualstar Corporation and BKF Capital Group, which involve shared costs and reimbursements.